AVR anteris technologies global corp.

Ann: DurAVR First in Human Study 12 Month Results, page-11

  1. 252 Posts.
    lightbulb Created with Sketch. 45
    I agree Stezza,

    6. The 6-minute walk test distance (6MWTD) measuring patient exercise capacity after aortic
    valve replacement improved by 32% from baseline, with a 17% improvement from the 30-day
    result at 12 months.


    If I read this correctly, 83% of the improvement in exercise tolerance occurred after 30 days and the remaining 17% over the following 11 months.
    That is more like 21% improvement experienced over the 11 months (17%) relative to that achieved over the first 30 days (83%) compared to baseline.......not a lot of difference between 17 and 21, but it shows considerable ongoing improvement.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$5.91
Change
-0.210(3.43%)
Mkt cap ! $91.59M
Open High Low Value Volume
$6.01 $6.08 $5.85 $44.71K 7.43K

Buyers (Bids)

No. Vol. Price($)
1 857 $5.83
 

Sellers (Offers)

Price($) Vol. No.
$6.08 260 1
View Market Depth
Last trade - 15.51pm 26/06/2025 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.